Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 44

1.

Csf2 and Ptgs2 Epigenetic Dysregulation in Diabetes-prone Bicongenic B6.NODC11bxC1tb Mice.

Garrigan E, Belkin NS, Seydel F, Han Z, Carter J, McDuffie M, Morel L, Peck AB, Clare-Salzler MJ, Atkinson M, Wasserfall C, Davoodi-Semiromi A, Shi JD, Haskell-Luevano C, Yang LJ, Alexander JJ, Cdebaca A, Piliant T, Riggs C, Amick M, Litherland SA.

Genet Epigenet. 2015 Oct 11;7:5-17. doi: 10.4137/GEG.S29696.

2.

Activation of the NLRP3 inflammasome in association with calcium oxalate crystal induced reactive oxygen species in kidneys.

Joshi S, Wang W, Peck AB, Khan SR.

J Urol. 2015 May;193(5):1684-91. doi: 10.1016/j.juro.2014.11.093.

3.

Regulation of macromolecular modulators of urinary stone formation by reactive oxygen species: transcriptional study in an animal model of hyperoxaluria.

Khan SR, Joshi S, Wang W, Peck AB.

Am J Physiol Renal Physiol. 2014 Jun 1;306(11):F1285-95. doi: 10.1152/ajprenal.00057.2014.

4.
6.

NADPH oxidase as a therapeutic target for oxalate induced injury in kidneys.

Joshi S, Peck AB, Khan SR.

Oxid Med Cell Longev. 2013;2013:462361. doi: 10.1155/2013/462361. Review.

7.

The important role of T cells and receptor expression in Sjögren's syndrome.

Karabiyik A, Peck AB, Nguyen CQ.

Scand J Immunol. 2013 Aug;78(2):157-66. doi: 10.1111/sji.12079. Review.

8.

Type I interferon receptor deficiency prevents murine Sjogren's syndrome.

Szczerba BM, Rybakowska PD, Dey P, Payerhin KM, Peck AB, Bagavant H, Deshmukh US.

J Dent Res. 2013 May;92(5):444-9. doi: 10.1177/0022034513483315.

9.

Systems analysis of primary Sjögren's syndrome pathogenesis in salivary glands identifies shared pathways in human and a mouse model.

Horvath S, Nazmul-Hossain AN, Pollard RP, Kroese FG, Vissink A, Kallenberg CG, Spijkervet FK, Bootsma H, Michie SA, Gorr SU, Peck AB, Cai C, Zhou H, Wong DT.

Arthritis Res Ther. 2012 Nov 1;14(6):R238. doi: 10.1186/ar4081.

10.

Apocynin-treatment reverses hyperoxaluria induced changes in NADPH oxidase system expression in rat kidneys: a transcriptional study.

Joshi S, Saylor BT, Wang W, Peck AB, Khan SR.

PLoS One. 2012;7(10):e47738. doi: 10.1371/journal.pone.0047738.

11.

Gene therapy using IL-27 ameliorates Sjögren's syndrome-like autoimmune exocrinopathy.

Lee BH, Carcamo WC, Chiorini JA, Peck AB, Nguyen CQ.

Arthritis Res Ther. 2012 Jul 24;14(4):R172. doi: 10.1186/ar3925.

12.

Transcriptome analysis of the interferon-signature defining the autoimmune process of Sjögren's syndrome.

Peck AB, Nguyen CQ.

Scand J Immunol. 2012 Sep;76(3):237-45. doi: 10.1111/j.1365-3083.2012.02749.x.

13.

Local delivery of AAV2-CTLA4IgG decreases sialadenitis and improves gland function in the C57BL/6.NOD-Aec1Aec2 mouse model of Sjögren's syndrome.

Yin H, Nguyen CQ, Samuni Y, Uede T, Peck AB, Chiorini JA.

Arthritis Res Ther. 2012 Feb 27;14(1):R40. doi: 10.1186/ar3753.

14.

B-cell tolerance defects in the B6.Aec1/2 mouse model of Sjögren's syndrome.

Meng W, Li Y, Xue E, Satoh M, Peck AB, Cohen PL, Eisenberg RA, Luning Prak ET.

J Clin Immunol. 2012 Jun;32(3):551-64. doi: 10.1007/s10875-012-9663-6.

15.

The current concept of T (h) 17 cells and their expanding role in systemic lupus erythematosus.

Perry D, Peck AB, Carcamo WC, Morel L, Nguyen CQ.

Arthritis. 2011;2011:810649. doi: 10.1155/2011/810649.

16.

Enzymatic dissolution of calcium and struvite crystals: in vitro evaluation of biochemical requirements.

Thalji NK, Richards NG, Peck AB, Canales BK.

Urology. 2011 Sep;78(3):721.e13-721.e17. doi: 10.1016/j.urology.2011.04.046.

17.

Sjögren's syndrome: studying the disease in mice.

Delaleu N, Nguyen CQ, Peck AB, Jonsson R.

Arthritis Res Ther. 2011 Jun 13;13(3):217. doi: 10.1186/ar3313. Review.

18.

Gene expression profiling of early-phase Sjögren's syndrome in C57BL/6.NOD-Aec1Aec2 mice identifies focal adhesion maturation associated with infiltrating leukocytes.

Peck AB, Saylor BT, Nguyen L, Sharma A, She JX, Nguyen CQ, McIndoe RA.

Invest Ophthalmol Vis Sci. 2011 Jul 29;52(8):5647-55. doi: 10.1167/iovs.11-7652.

19.

Pathogenic effect of interleukin-17A in induction of Sjögren's syndrome-like disease using adenovirus-mediated gene transfer.

Nguyen CQ, Yin H, Lee BH, Carcamo WC, Chiorini JA, Peck AB.

Arthritis Res Ther. 2010;12(6):R220. doi: 10.1186/ar3207.

20.

IL17: potential therapeutic target in Sjögren's syndrome using adenovirus-mediated gene transfer.

Nguyen CQ, Yin H, Lee BH, Chiorini JA, Peck AB.

Lab Invest. 2011 Jan;91(1):54-62. doi: 10.1038/labinvest.2010.164.

Items per page

Supplemental Content

Loading ...
Support Center